CooperVision MiSight FDA approval for Myopia Management

with No Comments

Interview with Stuart Cockerill, Head of Commercial Operations CooperVision Specialty EyeCare about the FDA approval of the MiSight daily contact lens for Myopia Management.

Interview was held by Dr. Oliver Woo during the EurOK 2019 in Cluj.

From Press Release Nov 18th 2019:

MiSight® 1 day will launch in the U.S. as part of a CooperVision myopia management initiative beginning in March 2020. The lens is already being successfully worn by thousands of myopic children in other parts of the world, including Canada, the United Kingdom, Spain and Australia, where age ranges for initial fitting may vary7.

FDA News release:

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed. - the web application for myopia control